The presence of overlapping quality of life symptoms in primary antibody deficiency (PAD) and chronic fatigue syndrome (CFS).
Bansal, Rhea A, Tadros, Susan, Bansal, Amolak S · Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2020 · DOI
Quick Summary
This study looked at whether people with primary antibody deficiency (PAD)—a condition where the immune system doesn't make enough protective proteins—also experience ME/CFS-like symptoms. Researchers sent questionnaires to over 680 PAD patients and found that about 16% of those who responded had symptoms matching ME/CFS criteria, which is much higher than the general population. The study also found that sleep problems, fatigue, anxiety, and low mood were very common in PAD patients.
Why It Matters
This study reveals that ME/CFS-like symptoms are substantially more common in PAD patients than in the general population, suggesting potential shared pathophysiological mechanisms or that immunological dysfunction may contribute to ME/CFS symptomatology. Understanding this overlap could inform both diagnostic approaches and treatment strategies for ME/CFS patients. The findings highlight the importance of screening for fatigue, sleep disturbance, and mood symptoms in immunocompromised populations.
Observed Findings
16.25% of PAD patients with adequate questionnaire responses met CFS diagnostic criteria
60% of responding PAD patients reported sleep disturbance
Estimated minimum CFS prevalence of 4% in PAD population (8-fold higher than 0.5% community estimate)
Significant positive correlation between fatigue severity and presence of anxiety and depression
No significant association between self-reported fatigue and lung damage
Inferred Conclusions
Fatigue, sleep disturbance, and mood alterations are substantially more prevalent in PAD patients than in the general population
Routine screening for fatigue, sleep problems, and mood symptoms should be implemented in PAD patient care
CFS treatment strategies may be beneficial for improving quality of life in PAD patients
The overlap in symptoms suggests potential shared or related pathophysiological mechanisms worth investigating
Remaining Questions
What mechanisms explain the high frequency of ME/CFS-like symptoms in PAD patients—immunological dysfunction, chronic infection, or other factors?
What This Study Does Not Prove
This study does not establish causation between PAD and ME/CFS, nor does it prove that PAD causes ME/CFS symptoms. The high response bias (patients with fatigue more likely to complete questionnaires) means the actual prevalence estimates may not be reliable. The cross-sectional design cannot determine whether symptoms preceded PAD diagnosis or vice versa, and symptom overlap does not necessarily indicate a shared mechanism.
Tags
Symptom:Unrefreshing SleepFatigue
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory Only
Does immunoglobulin replacement therapy adequately address fatigue and sleep symptoms, or do additional interventions targeting CFS-like symptoms improve outcomes?
Could response bias have significantly skewed prevalence estimates, and what is the true prevalence of ME/CFS in the PAD population?
Are there distinct phenotypes of fatigue in PAD (immunological vs ME/CFS-like) that require different treatment approaches?